↓ Skip to main content

The Potential of Cell-based Therapy for Diabetes and Diabetes-related Vascular Complications

Overview of attention for article published in Current Diabetes Reports, January 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
38 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Potential of Cell-based Therapy for Diabetes and Diabetes-related Vascular Complications
Published in
Current Diabetes Reports, January 2014
DOI 10.1007/s11892-013-0469-6
Pubmed ID
Authors

Aaron Liew, Timothy O’Brien

Abstract

Cell therapy has enormous potential for the treatment of conditions of unmet medical need. Cell therapy may be applied to diabetes mellitus in the context of beta cell replacement or for the treatment of diabetic complications. A large number of cell types including hematopoietic stem cells, mesenchymal stem cells, umbilical cord blood, conditioned lymphocytes, mononuclear cells, or a combination of these cells have been shown to be safe and feasible for the treatment of patients with diabetes mellitus. The first part of this review article will focus on the current perspective of the role of embryonic stem cells and inducible pluripotent stem cells for beta cell replacement and the current clinical data on cell-based therapy for the restoration of normoglycemia. The second part of this review will highlight the therapeutic role of MSCs in islet cells cotransplantation and the management of diabetes related vascular complications.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Mexico 1 3%
China 1 3%
Ireland 1 3%
Unknown 34 89%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 26%
Researcher 9 24%
Student > Ph. D. Student 5 13%
Other 4 11%
Student > Master 4 11%
Other 3 8%
Unknown 3 8%
Readers by discipline Count As %
Medicine and Dentistry 12 32%
Agricultural and Biological Sciences 7 18%
Biochemistry, Genetics and Molecular Biology 6 16%
Engineering 3 8%
Nursing and Health Professions 1 3%
Other 4 11%
Unknown 5 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 April 2014.
All research outputs
#20,228,822
of 22,754,104 outputs
Outputs from Current Diabetes Reports
#922
of 1,006 outputs
Outputs of similar age
#266,191
of 307,500 outputs
Outputs of similar age from Current Diabetes Reports
#22
of 24 outputs
Altmetric has tracked 22,754,104 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,006 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 307,500 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.